Training scientists to develop imaging techniques for neurodegenerative diseases
Translational Imaging Research Program in Radiopharmaceutical Sciences
This program is teaching future scientists how to use special imaging techniques to spot early signs of Alzheimer's and similar diseases, helping to improve diagnosis and treatment for patients.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10911873 on NIH RePORTER |
What this research studies
This program focuses on training the next generation of scientists in the field of PET molecular imaging, specifically aimed at creating and translating radiotracers that can noninvasively detect the biological changes associated with neurodegenerative diseases. Participants will learn from leading experts at the Mallinckrodt Institute of Radiology and collaborate with various departments to explore new biomarkers for Alzheimer's disease and related disorders. The training will enhance skills in imaging research, facilitating early disease detection and improving treatment strategies for patients. This initiative aims to bridge the gap between laboratory research and clinical application.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or diagnosed with neurodegenerative diseases such as Alzheimer's disease.
Not a fit: Patients with conditions unrelated to neurodegenerative diseases or those who do not have access to advanced imaging technologies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of neurodegenerative diseases, improving patient outcomes through timely intervention.
How similar studies have performed: Previous research in PET imaging and radiopharmaceuticals has shown promise in enhancing the detection and understanding of neurodegenerative diseases, indicating a strong foundation for this program.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Sharma, Vijay — Washington University
- Study coordinator: Sharma, Vijay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.